Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03829488Phase 3Completed
Phase 3, randomised, double-blind trial of plasma-lyte in delayed graft function (DGF) (2 arms), sponsored by The University of Queensland. Primary endpoint: Delayed Graft Function at 7 days. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03829488.